Author

M. L. Mallory

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

R. S. Baric· 3 shared D. Montefiori· 2 shared J. E. Munt· 2 shared A. Carfi· 1 shared A. D. Curtis· 1 shared A. Eaton· 1 shared A. Foulger· 1 shared A. Hamer· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

R. S. Baric

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes

B. Kapingidza, D. J. Marston, C. Harris, D. Wrapp, K. Winters, D. Mielke, L. Xiaozhi, Q. Yin, A. Foulger, R. Parks, M. Barr, A. Newman, A. Schaefer, A. Eaton, J. M. Flores, , M. L. Azoitei

This study designs engineered immunogens targeting conserved coronavirus epitopes to elicit broad-spectrum antibodies, showing protection in mice against live virus challenge.

bioRxiv · Feb 27, 2023Immunology

Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2

Y. Feng, M. Yuan, J. M. Powers, M. Hu, J. E. Munt, P. S. Arunachalam, S. R. Leist, L. Bellusci, L. E. Adams, S. Sundaramurthy, L. M. Shirreff, M. L. Mallory, T. D. Scooby, A. Moreno, D. T. OHagan, , B. Pulendran

This study identifies potent pan-sarbecovirus neutralizing antibodies from vaccinated macaques, showing broad neutralization against SARS-CoV-2 variants and related viruses.

bioRxiv · Jan 19, 2023 · PreprintImmunology

Thiol-based mucolytics exhibit antiviral activity against SARS-CoV-2 through allosteric disulfide disruption in the spike glycoprotein

Y. Shi, A. Zeida, C. E. Edwards, M. L. Mallory, S. Sastre, M. R. Machado, R. J. Pickles, L. Fu, K. Liu, J. Yang, R. S. Baric, R. C. Boucher, R. Radi, K. S. Carroll

This study shows thiol-based mucolytics inhibit SARS-CoV-2 by disrupting disulfides in the spike protein, reducing ACE2 binding and viral infection.

bioRxiv · Jul 1, 2021Microbiology

SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques

C. G. Garrado, A. D. Curtis, M. Dennis, S. H. Pathak, H. Gao, D. Montefiori, M. Tomai, C. B. Fox, P. A. Kozlowski, T. Scobey, J. E. Munt, M. L. Mallory, P. T. Saha, M. G. Hudgens, L. C. Lindesmith, , S. R. Permar

This study evaluates two SARS-CoV-2 vaccines in infant rhesus macaques, finding both induce durable antibody and T cell responses without adverse effects.

bioRxiv · Apr 5, 2021Immunology